Aberdeen Group
HCAT icon

Aberdeen Group’s Health Catalyst HCAT Stock Holding History

Aberdeen Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,422,201
Closed -$20.6M – 938
2022
Q2 		$20.6M Sell
1,422,201
-20,383
-1% -$348K 0.06% 278
2022
Q1 		$37.7M Buy
1,442,584
+345,137
+31% +$9.79M 0.1% 219
2021
Q4 		$43.5M Buy
1,097,447
+100,829
+10% +$4.6M 0.1% 213
2021
Q3 		$49.8M Buy
996,618
+992,372
+23,372% +$54.1M 0.11% 190
2021
Q2 		$236K Buy
+4,246
New +$226K ﹤0.01% 992
2020
Q2 		– Sell
-23,060
Closed -$603K – 933
2020
Q1 		$603K Buy
+23,060
New +$705K ﹤0.01% 818

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return